Leveraging synthetic lethality across EP300-mutant solid cancers through selective CBP degradationMOLECULAR CANCER THERAPEUTICSIF5.52024-06-100PRE
Establishing the cellular and molecular impacts of the dual BRM/BRG1 inhibitor FHD-286 on pre-clinical models of non-small cell lung cancer (NSCLC)MOLECULAR CANCER THERAPEUTICSIF5.52023-12-010PRE
The dual BRG1/BRM (SMARCA4/2) inhibitor FHD-286 induces functional differentiation and splicing defects in preclinical models of acute myeloid leukemia (AML)MOLECULAR CANCER THERAPEUTICSIF5.52023-12-010PRE
BMI1 is required for melanocyte stem cell maintenance and hair pigmentationPIGMENT CELL & MELANOMA RESEARCHIF2.62023-05-035OA
Genome-wide CRISPR screen identifies PRC2 and KMT2D-COMPASS as regulators of distinct EMT trajectories that contribute differentially to metastasisNATURE CELL BIOLOGYIF19.12022-04-1160OA
An EMT-primary cilium-GLIS2 signaling axis regulates mammogenesis and claudin-low breast tumorigenesisSCIENCE ADVANCESIF12.52021-10-2920OAAI
Characterization of Human iPSC-RPE on a Prosthetic Bruch's Membrane Manufactured From Silk FibroinINVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCEIF4.72018-06-0530OAAI
Pharmacological Modulation of Photoreceptor Outer Segment Degradation in a Human iPS Cell Model of Inherited Macular DegenerationMOLECULAR THERAPYIF122015-11-0160OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向